IS SCREENING OF DEPRESSIVE SYMPTOMS USEFUL AT THE PATIENTS WITH CARDIOVASCULAR DISEASE?
|
|
- Harvey Bailey
- 5 years ago
- Views:
Transcription
1 IS SCREENING OF DEPRESSIVE SYMPTOMS USEFUL AT THE PATIENTS WITH CARDIOVASCULAR DISEASE? Elena Călinescu 1, Ioana Daha 2, Cornelia Călinescu 3, Gheorghe Andrei Dan 4 1 Resident in Psychiatry at the Clinical Hospital of Psychiatry Prof. Dr. Al. Obregia, Berceni Road No , Bucharest, Romania. Tel ecalinescu@yahoo.com. 2 MD internal medicine and cardiology, Dept. of Cardiology, Colentina Hospital, Bucharest. 3 Resident in cardiology at Institute for Cardiovascular Diseases "C.C.Iliescu", Bucharest. 4 Cardiologist senior, MD, PhD, University Professor at Univ. of Medicine and Pharmarmacy "Carol Davila" Bucharest; Head Dept. of Cardiology, Colentina Hospital, Bucharest. Received December 08, 2010, Revised February 28, 2011, Accepted April 06, Abstract: The influence of affective disease on the cardiovascular system is a known fact, even though, because of opposite scientific results, a correlation between depressive symptoms and the etiology, evolution or prognosis of cardiovascular disease hasn't been proved yet. Our approach is the result of numerous studies showing the negative influence that depressive symptoms have on the evolution and prognosis of cardiovascular diseases. We are trying, through this article to draw attention on the importance of searching depressive symptoms on patients with cardiovascular disease, in order to prevent a possible severe coronary event, to improve the clinical condition of the patient and to provide the best medical care for patients suffering from cardiovascular disease. Key words: correlations, prognostic factors, depression, anxiety, ischemic heart disease. Rezumat: Influența tulburărilor din sfera psihoafectivă asupra sistemului cardiovascular constituie un truism, cu toate că, rezultatele științifice contradictorii nu pot susține, până în prezent, o legatură clară între simptomele depresive și etiopatogenia, evoluția și prognosticul bolilor cardiovasculare. Demersul nostru este urmarea numeroaselor studii care arată că, simptomele depresive influențează negativ evoluția și prognosticul bolilor cardiovasculare. Încercăm, prin acest articol, să atragem atenția asupra importanței screening-ului simptomelor depresive la pacienții cu boli cardiovasculare în scopul prevenirii unui posibil eveniment coronarian sever, îmbunătăţirii stării clinice și acordării de îngrijiri medicale optime a pacienților cu boli cardiovasculare. Cuvintele cheie: corelații, factori de prognostic, depresie, anxietate, boala cardiacă ischemică Demographic ageing and industrialization, which includes urbanization associated with a changing lifestyle - with a powerful influence of stress, diet and sedentary lifestyle - led to a continuous increase in the incidence and prevalence of depressive and cardiovascular disease, especially in developed countries. Depression lifetime prevalence is 7% - 14% for males and 20% - 25% for females (1, 2). Most studies show that depression has the higher lifetime prevalence (approximately 17%) of all mental disorders (3). Follow-up studies after 2006 show that the incidence of depression is approximately 20% (2). About 30% of the population over 60 years with a somatic disease has associated depressive symptoms (1). 1
2 A study carried out by the World Health Organization, World Bank and Harvard University concluded that, ever since 1990, depression is the fourth disease cause worldwide (1, 4). Depression has been designated by WHO in 2001 as a worldwide chronic disease, with the potential to become the leading cause of morbidity by 2020 (5). Cardiovascular diseases represent 48% of all deaths in Europe, with coronary artery disease as the most common cause (1 in 5 deaths) (6). Since 1950 cardiovascular diseases have become the leading cause of death in developed countries, the same thing happened in developing countries since 2001, so that, these days, cardiovascular diseases are the leading cause of death worldwide. In Romania, the prevalence of cardiovascular diseases also comes first, with more than 37 cases per 100 people examined, age over 15 years. It is estimated that in Romania there are about 7 million people with cardiovascular disease (2.8 million representing those with ischemic heart disease). The incidence of cardiovascular diseases in Romania was 256,4 / inhabitants in 2004 (7). The relationship between the "state of mind" and the heart can be found in vocabulary and literary works from ancient times, although, for a long period of time, there were no scientific data to confirm it. In 1628, William Harvey was the first to accurately describe the circulatory system and later expressed his opinion on the relationship between the heart and mind: "for each mental condition associated with pain or pleasure, hope or fear, an agitation occurs, whose influence extends to the heart ". This possible association has received little attention for more than 300 years. Only in the mid 70s reports appear about the impact of negative emotions on prognosis of myocardial infarction and also reports of a possible causal relationship between depression and myocardial infarction. In 1993, Frasure-Smith and colleagues published the outcomes of a prospective study, showing that, among other factors, depression is a significant predictor of mortality from myocardial infarction, and major depression is an independent risk factor for mortality in the first 6 months after a myocardial infarction (8). After 1993, numerous studies revealed consistent correlations between depression, anxiety and ischemic heart disease and also mortality from ischemic heart disease. Other studies considered that there is no significant relationship between depressive disorders and ischemic heart disease or cardiovascular disease evolution and prognosis. A recent meta-analysis which includes 22 studies suggested that the effects of post myocardial infarction depression on the cardiac prognosis have been mistaken with the severity of cardiac infarction. However, post myocardial infarction depression was associated with a risk times higher of all-cause mortality, cardiac mortality and new cardiovascular events. Among the studies that reported a statistically significant effect of depression on the severity of myocardial infarction, four studies have found depression to be an independent risk factor for myocardial infarction and other four studies found a less significant connection between depression and myocardial infarction (9). Note that there are studies that failed to confirm a statistical significant relationship between depression and myocardial infarction prognosis. A baseline survey which included people from 52 countries on five continents, published in 2004 (the INTERHEART study) has identified nine risk factors, easy to prove, responsible of over 90% of cases for risk of a cardiovascular event: smoking, dyslipidemia, hypertension, diabetes, obesity, diet, sedentary lifestyle, use of ethanol, psychosocial factors (work-related stress and other stressful events, the perception of inability to control existential situations, lack of social support) (10). Beside these risk factors the predisposing role of hereditary factors (genetic 2
3 vulnerability) is well known, in particular, family history for premature ischemic heart disease (IHD), defined as IHD in first degree relatives, males, age <50 years and females, age <65 years ) (11). The role of age is obvious, over 83% of people with coronary heart disease are over 65 years, and the risk for IHD in both sexes increases with age, with specification that the incidence of IHD is lower in women than in men before the age of 50 years; after menopause, cardiovascular risk in women gradually increases, becoming similar to that of men in the eighth decade for life (11). It is estimated that depressive symptoms and in particular major depressive disorder is undiagnosed and untreated. Studies show that among patients with mental disorders, 30% - 60% are not diagnosed (12). So, both patients with cardiovascular disease and patients with other somatic diseases may have undiagnosed depressive symptoms (13). Costs associated with somatic patients hospitalized for various diseases are double for those suffering of depression than for those without depression (14). Costs for the treatment of depressive disorder in 1990's America, were approximately 44 billion$, and the only way to reduce these costs was to restrict patient access to mental health care (15, 16, 17). Of those who seek help and treatment for depressive symptoms, more than half addressed themselves to the family doctor instead of seeking help from the mental health care system. In America, in 1997, only two out of 10 patients with depression were receiving psychiatric treatment from a psychiatrist (18). It is estimated that the prevalence of depression (major depressive disorder) among patients with heart disease is between 15 and 23% (19, 20, 21, 22, 23, 24). Depression is about two times more common in women with cardiovascular disease than in men (25). In patients with known cardiac disease, depressive disorder is responsible for an increase of approximately 3-4 fold increased risk of cardiovascular mortality (20, 26, 27, 28, 29). Diagnosis and treatment of major depression is important because many international studies have shown that depressive symptoms are a predictor for development of cardiovascular disease and unfavorable prognosis. In this respect we will discuss the changes, the factors predictive role without reference to other cardiac markers (troponin, natriuretic peptides, etc.) and neuromediators of depression (serotonergic, noradrenergic, dopaminergic, etc.). Depression is associated with multiple physiological changes that can adversely contribute to the development and prognosis of heart disease. Patients with depressive symptoms present in response to emotional stress, the activation of the sympathetic nervous system and the hypothalamic-pituitary-adrenal cortical system. Following the activation of the two systems appear: hipercortizolemia, high levels of catecholamine in the blood, abnormal platelet activation, increased inflammatory markers and endothelial dysfunction. These physiological changes are also present in depressed patients without heart disease. The disappearance of the two systems stressors should return to their basal position (30, 31, 32). Genetic predisposition, such as the serotonin transporter gene polymorphism with environmental factors could explain why some people adapt to stress factors, while others develop depression (33). Excessive activation of hypothalamic-pituitary-adrenal cortical growth is manifested by the corticotrophin releasing factor (CRH), elevated levels of cortisol and catecholamines (adrenaline and noradrenalin) and resistance to dexamethasone suppression test. Catecholamines leads to vasoconstriction, which may be beneficial in the short term heart rate response to stress, but long term can lead to heart failure. Increased levels of catecholamines in the blood are related to cardiac mortality by left ventricular dysfunction and heart failure (34, 35, 36, 37). 3
4 Increased activation of blood platelets leads to platelet aggregation and increase clot formation. In response to activation, platelets secrete serotonin, which acts as an agonist at 5- HT2 receptors and directly contribute to increased platelet aggregation and arterial vasoconstriction (38, 39, 40). It have shown similarities between the platelets 5HT2A receptors and 5HT2A receptors on the serotonergic neurons. It was also shown that platelets and brain serotonin transporter (SERTS) are encoded by the same genes. Serotonin-mediated platelet activation is assumed to be the "key" that would explain some pathogenetic relationship between depression and cardiovascular disease (41). Increased inflammatory response was detected in patients with depression by increasing levels of acute phase proteins (for ex. protein C reactive nonspecific inflammatory marker) and non inflammatory cytokines (eg. interleukins 1 and 6, tumor necrosis factor). It has been shown in multiple studies that these inflammatory markers meet in acute coronary syndrome, heart failure, and atherosclerosis. (42, 43, 44). Behavioral changes don t influence the evolution and unfavorable prognosis of depression associated with cardiovascular disease through directly mechanisms, but may become a barrier to the provision of optimal care. Thus, patients with depressive disorder may be less adherent to therapy, lifestyle modifications (eg. stop smoking, exercise, weight monitoring) and even heart dispensary (return to control, monitor cardiac function), compared with those without depression. Another clinical possibility is depressive disorder secondary to cardiac disease not associated with multiple other co-morbidities. In this case the negative outcome is due to the worsening of the heart disease and not by the depressive disorder itself (45). Numerous studies support the need to establish early detection and treatment of depression in patients with cardiovascular disease for the following reasons: - poor diagnosed depression in patients with medical conditions and therefore those with cardiovascular disease - as a co-morbidity, depression contributes to the worsening of the symptoms, prognosis and the growth of mortality from cardiovascular disease - if depression influences the physiological mechanisms of cardiovascular disease, early diagnosis and treatment of depression may lead to an evolution and a better prognosis by returning to the basal function of these mechanisms - if depression affects cardiovascular disease through behavioral changes, early diagnosis and treatment of depression can improve adherence to therapy, changing lifestyles and cardiology dispensary. Current knowledge explains not only through specific mechanisms (genetic, physiological, biochemical, etc.): (a) the relationship between depression and cardiovascular disease development and prognosis, (b) if a patient with depression may reduce the risk of cardiovascular death and serious cardiovascular events. Social, demographic and medical variables don t allow early diagnosis of depressive symptoms, including patients with cardiovascular disease. Identification of biochemical markers for depression used in research, remains a goal in current practice. It has been shown that antidepressants are serotonin reuptake mechanism (SSRIs) (SADHART study, CREATE study) are more effective than tricyclic antidepressants (adverse side effects fewer in number) in patients with cardiovascular disease, especially in elderly patients (27, 50). The mechanism by which SSRIs reduce the risk of cardiovascular events such as inhibition of platelet serotonin uptake, mobilization of intracellular calcium secondary to 4
5 increased bleeding time (known side effect of SSRIs), leading to lower risk of developing coronary thrombus (27, 50). Dual Antidepressants have also proven efficacy and tolerability in patients who had myocardial infarction and depression (study MIND - IT). Psychotherapy based on cognitive - behavioral interventions (ENRICHD study) was also taken into account (51, 52). These studies, however, failed to demonstrate statistically significant benefits of the treatment of depression in cardiovascular disease. The most effective ways of treatment (psychopharmacological or psychotherapeutic) of patients with depression and cardiovascular disease remain to be determined. Future studies will identify the most effective ways of screening and treatment approach (psychopharmacological and psychotherapeutic), and monitoring of patients with depression and cardiovascular disease. Investigative strategies should be based on additional prospective studies of patients with cardiovascular disease and depression. At present, although specific mechanisms are not known exactly which depression influences unfavorable evolution and prognosis of cardiovascular disease, many studies consider that early diagnosis and treatment of depressive symptoms in patients with cardiovascular disease, contribute to the improvement of the clinical condition, the quality of life and increase survival of these patients. REFERENCES 1. Khandelwal S. Conquering Depression: You Can Get Out Of The Blues. WHO, 2001, Patten SB. Accumulation Of Major Depressive Episodes Over Time In A Prospective Study Indicates That Retrospectively Assessed Lifetime Prevalence Estimates Are Too Low. BMC Psychiatry 2009; 9: Alexopoulos GS. Mood Disorders. In: Sadock BJ, Sadock VA, Ruiz P (eds). Concise Textbook of Clinical Psychiatry. Philadelphia: Lippincott Williams and Wilkins, 2008, Ustün TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. Global Burden Of Depressive Disorders In The Year Br J Psychiatry. 2004;184: Lopez AD, Murry C. The Global Burden Of Disease, Nature Medicine 1998; 4(11): British Heart Foundation. European Cardiovascular Disease Statistics. London: British Heart Foundation, Șelaru A, Ginghină C. Epidemiologia bolilor cardiovasculare. In: Ginghină C. Mic tratat de cardiologie. București: Editura Academiei Române, 2010; Frasure-Smith N, Lesperance F, Talajic M: Depression Following Myocardial Infarction: Impact On 6-Month Survival. JAMA 1993; 270: de Jonge P, Ormel J, van den Brink RHS et al. Symptom Dimensions of Depression Following Myocardial Infarction and Their Relationship With Somatic Health Status and Cardiovascular Prognosis. Am J Psychiatry 2006;163: Yusuf S, Hawken S, Ounpuu S et al. Effect on Potentially Modifiable Risk Factors Associated with Myocardial Infarction in 52 Countries (the INTERHEART study). Lancet 2004;364(9438): Jurcuț R. Factorii de risc cardiovascular. In: Ginghină C. Mic tratat de cardiologie. București: Editura Academiei Române, 2010, Maruish M. Psychological Testing for Treatment Planing and Outcomes Assessment. New Jersey: Lawrence Erlbaum Associates Inc, 2004, Musselman DL, Evans DL, Nemeroff CB. The Relationship of Depression to Cardiovascular Disease: Epidemiology, Biology and Treatment. Arch Gen Psychiatry 1998; 55(7): Katon W, Von Korff M, Lin E, BushT, Ormel J. Adequacy And Duration Of Antidepressant Treatment In Primary Care. Medical Care 1992; 30(1): Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER. The Economic Burden Of Depression In Journal of Clinical Psychiatry 1993;54: Greenberg PE, Kessler RC, Birnabaum HG, Leong SA, Lowe SW, Berglund PA, Corey-Lisle PK. The Economic Burden of Depression in the United States: How Did It Change Between 1990 and 2000? Journal of Clinical Psychiatry 2003; 64(12):
6 17. Ginzberg F. Managed Care and the Competitive Market in Health Care. What They Can And Cannot Do. JAMA 1997; 277(22): Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA. National Trends In Outpatient Treatment of Depression. JAMA 2002; 287: Ariyo AA, Haan M, Tangen CM et al. Depressive Symptoms and Risks of Coronary Heart Disease and Mortality in Elderly Americans. Circulation 2000; 102: Lesperance F, Frasure-Smith N, Juneau M, Theroux P. Depression and 1-year Prognosis In Unstable Angina. Arch Intern Med 2000; 160: Carney RM, Freedland KE, Sheline YI, Weiss ES. Depression and Coronary Heart Disease: a Review for Cardiologists. Clin Cardiol 1997; 20: Schleifer SJ, Macari-Hinson MM, Coyle DA et al. The Nature and Course of Depression following myocardial infarction. Arch Intern Med 1989; 149: Jiang W, Alexander J, Christopher E et al. Relationship of Depression to Increased Risk of Mortality and Rehospitalization in Patients with Congestive Heart Failure. Arch Intern Med 2001; 161: Koenig HG. Depression in Hospitalized Older Patients with Congestive Heart Failure. Gen Hosp Psychiatry 1998; 20: Naqvi TZ, Naqvi S. Bairey-Merz CN. Gender Differences in the Link Between Depression and Cardiovascular Disease. Psychosom Med 2005; 67(Suppl 1):S Schulman J, Shapiro PA. Depression and Cardiovascular Disease. What is the Correlation? Psychiatric Times 2008; 25(9): Glassman AH, O Connor CM, Califf RM et al. Sertraline Treatment of Major Depression in Patients With Acute MI or Unstable Angina (SADHART). JAMA 2002; 288: Bush DE, Ziegelstein RC, Tayback M et al. Even Minimal Symptoms of Depression Increase Mortality Risk After Acute Myocardial Infarction. Am J Cardiol. 2001; 88: Welin C, Lappas G, Wilhelmsen L. Independent Importance of Psychosocial Factors for Prognosis After Myocardial Infarction. J Intern Med 2000; 247: Rozanski A, Blumenthal JA, Kaplan J. Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy. Circulation 1999; 99: Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C, Newman MF. Depression as a Risk Factor for Coronary Artery Disease: Evidence, Mechanisms, and Treatment. Psychosom Med 2004; 66: Lederbogen F, Gilles M, Maras A, Hamann B, Colla M, Heuser I, Deuschle M. Increased Platelet Aggregability in Major Depression? Psychiatry Res 2001; 102: Caspi A, Sugden K, Moffitt TE et al. Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT gene. Science. 2003; 301: Heit S, Owens MJ, Plotsky PM, Nemeroff CB. Corticotropin-Releasing Factor, Stress, and Depression. Neuroscientist 1997; 3: Otte C, Marmar CR, Pipkin SS et al. Depression and 24-hour Urinary Cortisol in Medical Outpatients with Coronary Heart Disease: Biol Psychiatry 2004; 56: Pepper GS, Lee RW. Sympathetic Activation In Heart Failure And Its Treatment With Beta-Blockade. Arch Intern Med 1999; 159: Benedict CR, Shelton B, Johnstone DE et al. Prognostic Significance of Plasma Norepinephrine in Patients with Asymptomatic Left Ventricular Dysfunction. Circulation 1996; 94: De Clerck F. Effects of Serotonin on Platelets and Blood Vessels. J Cardiovasc Pharmacol 1991; 17(suppl 5):S1-S Weyrich AS, Solis GA, Li KS et al. Platelet Amplification of Vasospasm. Am J Physiol 1992; 263(2): Atar D, Malinin A, Takserman A et al. Escitalopram, But Not Its Major Metabolites, Exhibits Antiplatelet Activity in Humans. J Clin Psychopharmacol 2006; 26: Wittstein IS. Depression, Anxiety, and Platelet Reactivity in Patients with Coronary Heart Disease. European Heart Journal 2010; 31: Maes M, Bosmans E, Meltzer HY et al. Interleukin-1 Beta: a Putative Mediator of HPA Axis Hyperactivity in Major Depression? Am J Psychiatry. 1993; 150: Miller GE, Stetler CA, Carney RM et al. Clinical Depression and Inflammatory Risk Markers for Coronary Heart Disease. Am J Cardiol 2002; 90: Bremmer MA, Beekman AT, Deeg DJ et al. Inflammatory Markers in Late-Life Depression: Results From a Population-Based Study. J Affect Disord 2008; 106:
7 45. Pozuelo L, Zhang J, Franco K, Tesar G, Penn M, Jiang W. Depression and Heart Disease: What do we Know and Where do we Headed? Cleveland Clinic Journal of Medicine 2009; 76(1): Bigger TJ, Glassman AH. The American Heart Association Science Advisory on Depression and Coronary Heart Disease: An Exploration of the Issues Raised. Cleveland Clinic Journal Of Medicine 2010; 77(S3):S12-S McManus D, Pipkin SS, Whooley MA. Screening for Depression in Patients withccoronary Hheart Disease (data from the Heart and Soul Study). Am J Cardiol 2005; 96: Löwe B, Unutzer J, Callahan CM, Perkins AJ, Kroenke K. Monitoring Depression Treatment Outcomes with the Patient Health Questionnaire-9. Med Care 2004; 42: Musselman DL, Evans DL, Nemeroff CB. The Relationship of Depression to Cardiovascular Disease. Epidemiology, Biology, and Treatment. Arch Gen Psychiatry 1998; 55: Lesperance F, Frasure-Smith N, Koszycki D et al. CREATE Investigators. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007; 297: van Melle JP, de Jonge P, Honig A et al. MIND-IT investigators. Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry 2007; 190: Berkman LF, Blumenthal J, Burg M et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA 2003; 289:
NHFA CONSENSUS STATEMENT ON DEPRESSION IN PATIENTS WITH CORONARY HEART DISEASE
NHFA CONSENSUS STATEMENT ON DEPRESSION IN PATIENTS WITH CORONARY HEART DISEASE Associate Professor David Colquhoun 19th October 2013 University of Queensland, Wesley & Greenslopes Hospitals, Brisbane,
More informationDepression in Peripheral Artery Disease: An important Predictor of Outcome. Goals. Goals. Marlene Grenon, MD Assistant Professor of Surgery, UCSF
Depression in Peripheral Artery Disease: An important Predictor of Outcome There are no conflicts of interest Marlene Grenon, MD Assistant Professor of Surgery, UCSF UCSF VASCULAR SURGERY SYMPOSIUM SAN
More informationNIH Public Access Author Manuscript Am J Cardiol. Author manuscript; available in PMC 2009 November 12.
NIH Public Access Author Manuscript Published in final edited form as: Am J Cardiol. 2005 October 15; 96(8): 1076 1081. doi:10.1016/j.amjcard.2005.06.037. Screening for Depression in Patients With Coronary
More informationCardiac Patients Psychosocial Needs. Cardiac Patients Psychosocial Needs
Cardiac Patients Psychosocial Needs Implications for Rehabilitation Programs and CACR Guidelines Jaan Reitav and Paul Oh Cardiac Rehabilitation & Secondary Prevention Program Cardiac Patients Psychosocial
More informationScreening for Depression in Patients With Coronary Heart Disease (Data from the Heart and Soul Study)
Screening for Depression in Patients With Coronary Heart Disease (Data from the Heart and Soul Study) David McManus, MD a,c, Sharon S. Pipkin, MPH c, and Mary A. Whooley, MD a,b,c, * Major depression is
More informationThe Bypassing the Blues Trial: Telephone-Delivered Collaborative Care for Treating Post-CABG Depression
The Bypassing the Blues Trial: Telephone-Delivered Collaborative Care for Treating Post-CABG Depression www.bypassingtheblues.pitt.edu Bruce L. Rollman, MD, MPH Professor of Medicine, Psychiatry, and Clinical
More informationNIH Public Access Author Manuscript Cleve Clin J Med. Author manuscript; available in PMC 2010 August 9.
NIH Public Access Author Manuscript Published in final edited form as: Cleve Clin J Med. 2010 July ; 77(Suppl 3): S20 S26. doi:10.3949/ccjm.77.s3.04. Depression and Cardiovascular Disease: Selected Findings,
More informationEffect of Depression on Five-Year Mortality After an Acute Coronary Syndrome
Effect of Depression on Five-Year Mortality After an Acute Coronary Syndrome Sherry L. Grace, PhD a,b, *, Susan E. Abbey, MD b,c, Moira K. Kapral, MD, MSc b,c,d, Jiming Fang, PhD d, Robert P. Nolan, PhD,
More informationM ajor depression after myocardial infarction (MI) is a
1656 CARDIOVASCULAR MEDICINE Rapid screening for major depression in postmyocardial infarction patients: an investigation using Beck Depression Inventory II items J C Huffman, F A Smith, M A Blais, M E
More informationConnections Between Depression and Heart Disease
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/focus-on-heart-health/connections-between-depression-and-heartdisease/4168/
More informationA Practical Strategy to Screen Cardiac Patients for Depression
A Practical Strategy to Screen Cardiac Patients for Depression Bruce L. Rollman, M.D., M.P.H. Associate Professor of Medicine and Psychiatry Center for Research on Health Care Division of General Internal
More informationDepression intervention via referral, education, and collaborative treatment (Project DIRECT): a pilot study
Executive summary of completed research Depression intervention via referral, education, and collaborative treatment (Project DIRECT): a pilot study Principal Investigator Jane McCusker, MD DrPH Co-investigators
More informationMyocardial infarction and depression: A review article
Myocardial infarction and depression: A review article Reza Bagherian-Sararoudi (1), Hamid Sanei (2), Ali Baghbanian (3) Abstract BACKGROUND: Depressive symptoms are common among post myocardial infarction
More informationPost-Myocardial Infarction Depression Summary
Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Number 123 Post-Myocardial Infarction Depression Summary Authors: Bush DE, Ziegelstein RC, Patel UV, Thombs BD, Ford DE,
More informationPsychological Factors and Cardiac Risk and Impact of Exercise Training Programs A Review of Ochsner Studies
The Ochsner Journal 7:167 172, 2007 facademic Division of Ochsner Clinic Foundation Psychological Factors and Cardiac Risk and Impact of Exercise Training Programs A Review of Ochsner Studies Carl J. Lavie,
More informationNIH Public Access Author Manuscript JAMA Intern Med. Author manuscript; available in PMC 2014 June 24.
NIH Public Access Author Manuscript Published in final edited form as: JAMA Intern Med. 2013 June 24; 173(12): 1150 1151. doi:10.1001/jamainternmed.2013.910. SSRI Use, Depression and Long-Term Outcomes
More informationCopyright Medinews (Cardiology) Limited Reproduction Prohibited
Meeting the psychological needs of cardiac patients: an integrated stepped-care approach within a cardiac rehabilitation setting Alison Child, Jane Sanders, Paul Sigel, Myra S Hunter Authors Alison Child
More informationSubjects with Elevated CRP Levels and Asymptomatic PAD Prone to Develop Cognitive Impairment
Subjects with Elevated CRP Levels and Asymptomatic PAD Prone to Develop Cognitive Impairment Pavel Dan Nanu 1, Sanda Maria Deme 1, Ramona Maria Chendereş 1 Abstract: The CRP is an independent predictor
More informationDepression among Patients with Coronary Artery Disease in Saudi Arabia
Depression among Patients with Coronary Artery Disease in Saudi Arabia 1 Naeem Alshoaibi, 2 Galya G. Alsharif, 3 Jumanah MS. Ardawi, 4 Lama Andijani, 5 Mohammad Alahdal, 6 Mohamed Nabil, Ama, 7 Imad Hameedullah
More informationUniversity of Groningen
University of Groningen Depression treatment after myocardial infarction and long-term risk of subsequent cardiovascular events and mortality Zuidersma, Marij; Conradi, Henk Jan; van Melle, Joost P.; Ormel,
More informationThe Neurobiology of Mood Disorders
The Neurobiology of Mood Disorders J. John Mann, MD Professor of Psychiatry and Radiology Columbia University Chief, Department of Neuroscience, New York State Psychiatric Institute Mood Disorders are
More informationData Alert #2... Bi o l o g y Work i n g Gro u p. Subject: HOPE: New validation for the importance of tissue ACE inhibition
Vascular Bi o l o g y Work i n g Gro u p c/o Medical Education Consultants, In c. 25 Sy l van Road South, We s t p o rt, CT 06880 Chairman: Carl J. Pepine, MD Professor and Chief Division of Cardiovascular
More informationGuilt Suicidality. Depression Co-Occurs with Medical Illness The rate of major depression among those with medical illness is significant.
1-800-PSYCH If you are obsessive-compulsive, dial 1 repeatedly If you are paranoid-delusional, dial 2 and wait, your call is being traced If you are schizophrenic, a little voice will tell you what number
More informationCOMPARISON OF THE BECK DEPRESSION INVENTORY-II AND GERIATRIC DEPRESSION SCALE AS SCREENS FOR DEPRESSION IN CARDIAC PATIENTS
The University of British Columbia COMPARISON OF THE BECK DEPRESSION INVENTORY-II AND GERIATRIC DEPRESSION SCALE AS SCREENS FOR DEPRESSION IN CARDIAC PATIENTS Gail D. Low University of British Columbia
More informationMale Sexual Dysfunction in Psychiatric Illnesses Sujit Kumar Kar 1, Saranya Dhanasekaran 1 Correspondence: gmail.
RESEARCH ARTICLE Open Access Male Sexual Dysfunction in Psychiatric Illnesses Sujit Kumar Kar 1, Saranya Dhanasekaran 1 Correspondence: drsujita@gmail.com; saranya296@ gmail.com Full list of author information
More informationHeart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United
Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United States, totaling about 750,000 individuals annually
More informationMODIFICATION OF SOME RISK FACTORS IN PATIENTS WITH STABLE ANGINA IN TREATMENT WITH BETA-BLOCKERS AND CALCIUM CHANNEL BLOKERS
Analele UniversităŃii din Oradea, Fascicula Ecotoxicologie, Zootehnie şi Tehnologii de Industrie Alimentară, 2013 MODIFICATION OF SOME RISK FACTORS IN PATIENTS WITH STABLE ANGINA IN TREATMENT WITH BETA-BLOCKERS
More informationComorbidity of Depression and Other Diseases
Comorbidity of Depression and Other Diseases JMAJ 44(5): 225 229, 2001 Masaru MIMURA Associate Professor, Department of Psychiatry, Showa University, School of Medicine Abstract: This paper outlines the
More informationDepression Can it ever be cured?
Depression Can it ever be cured? Disability, Relapses, and the Effect of Treatment Presented by Dr Julian Parmegiani MB BS FRANZCP 1208/370 Pitt St Sydney NSW 2000 12 August 2008 Claims & Underwriting
More informationUniversity of Groningen. Somatic depression in the picture Meurs, Maaike
University of Groningen Somatic depression in the picture Meurs, Maaike IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the
More informationDepression and survival in chronic heart failure: Does gender play a role?
European Journal of Heart Failure 9 (2007) 1018 1023 www.elsevier.com/locate/ejheart Depression and survival in chronic heart failure: Does gender play a role? Hermann Faller a,, Stefan Störk b, Marion
More informationLinda Carpenter, M.D.
Stress, Depression and Physical Health Linda Carpenter, M.D. Associate Professor of Psychiatry and Human Behavior and Medicine Alpert Medical School of Brown University Chief, Butler Hospital Mood Disorders
More informationComparison of the latency time of selective serotonin reuptake inhibitors and serotonin-noradrenaline reuptake inhibitors
Journal of Medicine and Medical Science Vol. 2(9) pp. 1085-1092, September 2011 Available online@ http://www.interesjournals.org/jmms Copyright 2011 International Research Journals Full Length Research
More informationREPORT FROM THE CANADIAN CHRONIC DISEASE SURVEILLANCE SYSTEM:
REPORT FROM THE CANADIAN CHRONIC DISEASE SURVEILLANCE SYSTEM: PROTECTING AND EMPOWERING CANADIANS TO IMPROVE THEIR HEALTH TO PROMOTE AND PROTECT THE HEALTH OF CANADIANS THROUGH LEADERSHIP, PARTNERSHIP,
More informationPost-Stroke Depression Primary Care Stroke Update: What s New in Best Practice Prevention & Care
Post-Stroke Depression Primary Care Stroke Update: What s New in Best Practice Prevention & Care Maria Hussain MD FRCPC Dallas Seitz MD PhD(c) FRCPC Division of Geriatric Psychiatry, Queen s University
More informationWho Cares About the Past?
Risk Factors, the New Calcium Score, Rheology and Atherosclerosis Progression Arthur Agatston 2/21/15 The Vulnerable Plaque vs. Plaque Burden CT Angiogram Is There a Role for Coronary Artery Calcium Scoring
More informationDepression and the Role of L-methylfolate
Depression and the Role of L-methylfolate Depression is a chronic and recurrent disease affecting more than 18 million people in the United States, ranking it, along with heart disease, cancer and diabetes,
More informationOutline. Understanding Placebo Response in Psychiatry: The Good, The Bad, and The Ugly. Definitions
Outline Understanding Placebo Response in Psychiatry: The Good, The Bad, and The Ugly Michael E. Thase, MD Professor of Psychiatry Perelman School of Medicine University of Pennsylvania and Philadelphia
More informationDepression is extremely prevalent
Depression is common in medically ill patients, and it presents a particular challenge to the primary care physician. Depression may exacerbate cardiovascular disease, diabetes, and irritable bowel syndrome.
More informationMeasurement-based Scales in Major Depressive Disorder:
This program is paid for by Otsuka Pharmaceutical Development & Commercialization, Inc. and Lundbeck, LLC. The speaker is a paid contractor of Otsuka Pharmaceutical Development and Commercialization, Inc.
More informationDepression, isolation, social support and cardiovascular rehabilitation in older adults
Depression, isolation, social support and cardiovascular rehabilitation in older adults B. Rauch ZAR Ludwigshafen Klinikum EuroPRevent 21 Prague some data to the actual situation Depression increases mortality
More informationDr.Rahiminejad Roozbeh Hospital TUMS
Dr.Rahiminejad Roozbeh Hospital TUMS Psychiatric disorders, particularly depression, anxiety and eating disorders, are prevalent in diabetes. Mental illness increases risk of diabetes and diabetic complications.
More informationPNEI NEWS PSYCHE, HEART AND BELLY. Stress, cardiopathies, diabetes, obesity how they are related
The review of the Italian association of psycho-neuro-endocrineimmunology Edited by Francesco Bottaccioli PNEI NEWS The new knowledge of science and health PSYCHE, HEART AND BELLY Stress, cardiopathies,
More information#268 APRIL 2016 Depression is a complex heterogeneous disorder, which may need a similarly heterogeneous offer of treatment
ARE CHRONIC INFLAMMATION AND ITS METABOLIC COUNTERPART, INSULIN RESISTANCE, THE COMMON DENOMINATORS FOR ALL CHRONIC BEHAVIORAL AND NEURODEGENERATIVE DISORDERS? A REVIEW OF THE EVIDENCE PART III THE COMPLICATED
More informationA comparison of diabetic complications and health care utilization in diabetic patients with and without
John A. Dufton, DC, MD, Wilson W. Li, BSc (Pharm), MD, Mieke Koehoorn, PhD A comparison of diabetic complications and health care utilization in diabetic patients with and without comorbid A Canadian cross-sectional
More informationCardiac Rehabilitation after Primary Coronary Intervention CONTRA
DEBATE SESSION Is there a role for cardiac rehabilitation in the modern era of Percutaneous coronary intervention and coronary artery bypass grafting? Cardiac Rehabilitation after Primary Coronary Intervention
More informationStudy Guide Unit 3 Psych 2022, Fall 2003
Psychological Disorders: General Study Guide Unit 3 Psych 2022, Fall 2003 1. What are psychological disorders? 2. What was the main treatment for some psychological disorders prior to the 1950 s? 3. What
More informationDepression and Physical Illnesses: an Update
Review Article Depression and Physical Illnesses: an Update M A Mohit 1, M M Maruf 2, H Ahmed 3, M T Alam 4 Abstract Many chronic illnesses have a strong effect on an individual's mental and emotional
More informationDepression in the Medically Ill
Mayo School of Continuous Professional Development Psychiatry in Medical Settings February 9 th, 2017 Depression in the Medically Ill David Katzelnick, M.D. Professor of Psychiatry, Mayo Clinic College
More informationHYPERTENSION; THE ICE BERG
The Professional Medical Journal DOI: 10.17957/TPMJ/15.2930 ORIGINAL PROF-2930 HYPERTENSION; THE ICE BERG 1. Senior Lecturer (Community Medicine). RIHS Islamabad. 2. Assistant Professor, Department of
More informationPost-Traumatic Stress Disorder (PTSD) Among People Living with HIV
Post-Traumatic Stress Disorder (PTSD) Among People Living with HIV Milton L. Wainberg, M.D. Associate Clinical Professor of Psychiatry College of Physicians and Surgeons Columbia University mlw35@columbia.edu
More informationCardiovascular Disorders Lecture 3 Coronar Artery Diseases
Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in
More information10/19/12. Depression in the Medically Ill. Ondria C. Gleason, MD Disclosures. Dr. Gleason has no disclosures to report
Depression in the Medically Ill Ondria C. Gleason, MD University of Oklahoma School of Community Medicine Tulsa, OK Ondria C. Gleason, MD Disclosures Dr. Gleason has no disclosures to report 1 Learning
More informationDecember 2014 MRC2.CORP.D.00011
This program is paid for by Otsuka America Pharmaceutical, Inc. and Lundbeck, LLC. The speaker is a paid contractor of Otsuka America Pharmaceutical, Inc. advice or professional diagnosis. Users seeking
More informationDepression and CV Disease A Depressing Story. Bertram Pitt, M.D. University of Michigan School of Medicine
A Depressing Story Bertram Pitt, M.D. University of Michigan School of Medicine Davos 2011 HF affects > 5 million people in the US 15-20% of patients with HF have depression Patients with HF + depression
More informationDespite tremendous progress in improving morbidity
Leveraging Remote Behavioral Health Interventions to Improve Medical Outcomes and Reduce Costs Reena L. Pande, MD, MSc; Michael Morris; Aimee Peters, LCSW; Claire M. Spettell, PhD; Richard Feifer, MD,
More informationStrategies to Gain Acceptance for Wellness/ Mind-Body Programs by Skeptical Residents and Clinical Faculty: Stress Physiology
Strategies to Gain Acceptance for Wellness/ Mind-Body Programs by Skeptical Residents and Clinical Faculty: Stress Physiology Michael D. Lumpkin, PhD Professor of Integrative Physiology and Biochemistry
More informationAngelo Compare 1, *, Elena Germani 2, Riccardo Proietti 3 and David Janeway 4
148 Clinical Practice & Epidemiology in Mental Health, 2011, 7, 148-156 Open Access Clinical Psychology and Cardiovascular Disease: An Up-to-Date Clinical Practice Review for Assessment and Treatment of
More informationCorrelations between Lifestyle and Ischemic Heart Disease in Young Patient
Correlations between Lifestyle and Ischemic Heart Disease in Young Patient PhD. Raluca IANULA (e-mail: ralucaciomag@yahoo.com) University Carol Davila, Bucharest, Romania ABSTRACT Myocardial infarction
More informationORIGINAL ARTICLE. treatment would reduce that
ORIGINAL ARTICLE Psychiatric Characteristics Associated With Long-term Mortality Among 361 Patients Having an Acute Coronary Syndrome and Major Depression Seven-Year Follow-up of SADHART Participants Alexander
More informationThe Changing Epidemiology of Acute Coronary Syndromes: Implications for practice: Dr. Sonia Anand, McMaster University
The Changing Epidemiology of Acute Coronary Syndromes: Implications for practice: Dr. Sonia Anand, McMaster University Expert Opinions CCS Vancouver, BC October 23, 2011 Overview of ACS Epidemiology: Global
More informationStress Reactions and. Depression After. Cardiovascular Events
Stress Reactions and Depression After Cardiovascular Events Kim G. Smolderen, PhD Tilburg University, the Netherlands Saint Luke s Mid America Heart Institute, Kansas City, MO ESC Munich 2012 Disclosures
More informationBRIEF REPORTS. Effectiveness of a Smartphone App for Guiding Antidepressant Drug Selection Colin Man; Cathina Nguyen; Steven Lin, MD
Effectiveness of a Smartphone App for Guiding Antidepressant Drug Selection Colin Man; Cathina Nguyen; Steven Lin, MD BACKGROUND AND OBJECTIVES: Major depression is a prevalent chronic disease in the United
More informationDEPRESSION HAS LONG BEEN
ORIGINAL CONTRIBUTION Depressive Symptoms, Health Behaviors, and Risk of Cardiovascular Events in Patients With Coronary Heart Disease Mary A. Whooley, MD Peter de Jonge, PhD Eric Vittinghoff, PhD Christian
More informationMULTIFACTORIAL ANALYSIS OF CARDIOVASCULAR RISK FACTORS IN A GROUP OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
2014 ILEX PUBLISHING HOUSE, Bucharest, Roumania http://www.jrdiabet.ro Rom J Diabetes Nutr Metab Dis. 21(4):327-333 doi: 10.2478/rjdnmd-2014-0040 MULTIFACTORIAL ANALYSIS OF CARDIOVASCULAR RISK FACTORS
More informationImpact of Exercise Training and Depression on Survival in Heart Failure Due to Coronary Heart Disease
Impact of Exercise Training and Depression on Survival in Heart Failure Due to Coronary Heart Disease Richard V. Milani, MD a, *, Carl J. Lavie, MD a, Mandeep R. Mehra, MBBS b, and Hector O. Ventura, MD
More informationHazard ratio for coronary heart disease mortality for SMI patients versus controls (18-49 yrs) Hazard ratio for stroke
By Michael Dixon Contents Background to Bipolar Disorder and cardiac risk Mood stabilisers and cardiac risk factors Background to Depression and cardiac risk Antidepressants and cardiac risk factors Any
More informationDepression in Late Life
Depression in Late Life Robert Madan MD FRCPC Geriatric Psychiatrist Key Learnings Robert Madan MD FRCPC Key Learnings By the end of the session, participants will be able to List the symptoms of depression
More informationReducing Psychosocial Stress: A Novel Mechanism of Improving Survival from Exercise Training
CLINICAL RESEARCH STUDY Reducing Psychosocial Stress: A Novel Mechanism of Improving Survival from Exercise Training Richard V. Milani, MD, Carl J. Lavie, MD Department of Cardiology, Ochsner Clinic Foundation,
More informationDepartment of Psychiatry & Behavioral Sciences. University of Texas Medical Branch
Depression in Childhood: Advances and Controversies in Treatment Karen Dineen Wagner, MD, PhD Marie B. Gale Centennial Professor & Vice Chair Department of Psychiatry & Behavioral Sciences Director, Division
More informationORIGINAL INVESTIGATION. Depression Is a Risk Factor for Coronary Artery Disease in Men
Depression Is a Risk Factor for Coronary Artery Disease in Men The Precursors Study ORIGINAL INVESTIGATION Daniel E. Ford, MD, MPH; Lucy A. Mead, ScM; Patricia P. Chang, MD; Lisa Cooper-Patrick, MD, MPH;
More informationDepressive Symptom Dimensions and Cardiovascular Prognosis among Women with Suspected Myocardial Ischemia
Depressive Symptom Dimensions and Cardiovascular Prognosis among Women with Suspected Myocardial Ischemia A Report from the NHLBI- Sponsored Women s Ischemia Syndrome Evaluation (WISE) Society of Behavioral
More informationRaluca Pavaloiu et al. - Clinical, Epidemiological and Etiopathogenic Study of Ischemic Stroke
Original Paper Clinical, Epidemiological and Etiopathogenic Study of Ischemic Stroke RALUCA PAVALOIU 1, L. MOGOANTA 2 1 Department of Neurology, Hospital of Neuropsychiatry Craiova, Romania 2 Department
More informationConsidering depression as a risk marker for incident coronary disease
Considering depression as a risk marker for incident coronary disease Dr Adrienne O'Neil Senior Research Fellow Melbourne School of Population & Global Health The University of Melbourne & Visiting Fellow
More informationInternational Journal of Basic and Applied Physiology
Cardiovascular Health Screening Of A Of Adults Residing In Ahmedabad City A Study Of Correlation Between Exercise, Body Mass Index And Heart Rate Jadeja Upasanaba*, Naik Shobha**, Jadeja Dhruvkumar***,
More informationObsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care
Obsessive-Compulsive Disorder Clinical Practice Guideline Summary for Primary Care CLINICAL ASSESSMENT AND DIAGNOSIS (ADULTS) Obsessive-Compulsive Disorder (OCD) is categorized by recurrent obsessions,
More informationBACPR -Annual Conference London 2017
BACPR -Annual Conference London 2017 Psychological Distress in Patients with Cardiac Conditions; Developing Skills in Integrated Care and the Development of the Increasing Access to Psychological Therapies
More informationCoronary Heart Disease. Raja Nursing Instructor RN, DCHN, Post RN. BSc.N
Coronary Heart Disease Raja Nursing Instructor RN, DCHN, Post RN. BSc.N 31/03/2016 Objectives Define coronary heart disease (CHD). Identify the causes and risk factors of CHD Discuss the pathophysiological
More informationAddressing Vascular Plaque Ruptures
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/addressing-vascularplaque-ruptures/3131/
More informationDiabetes and Depression
Journal of Stress Physiology & Biochemistry, Vol. 6 No. 3 2010, pp. 38-43 ISSN 1997-0838 Original Text Copyright 2010 by Abass Yavari, Naimeh Mashinchi REVIEW Abass Yavari 1, Naimeh Mashinchi 2 1 Department
More informationOnset and Recurrence of Depression as Predictors of Cardiovascular Prognosis in Depressed Acute Coronary Syndrome Patients: A Systematic Review
Regular Article DOI: 10.1159/000322633 Received: March 27, 2010 Accepted after revision: November 2, 2010 Published online: April 18, 2011 Onset and Recurrence of Depression as Predictors of Cardiovascular
More informationprivate patients centre Royal Brompton Heart Risk Clinic
private patients centre Royal Brompton Heart Risk Clinic Trust our experts to detect the early signs of heart disease Royal Brompton and Harefield Contents 3 Introduction to the Heart Risk Clinic 3 What
More informationBehavioral Psychology of the Cardiac Patient: Freud Behind the Stethoscope. Disclosures. The Plan. I have no conflicts of interest to disclose.
12 th Annual Oregon Cardiovascular Symposium June 7, 2015, Portland, Oregon Behavioral Psychology of the Cardiac Patient: Freud Behind the Stethoscope Adrienne H. Kovacs, PhD, CPsych Peter Munk Cardiac
More informationMoving Beyond the Monoamine Hypothesis to Examine the Fundamental Difference in. Physiological Mechanism. Myra Ahmad.
Ahmad 1 Moving Beyond the Monoamine Hypothesis to Examine the Fundamental Difference in Endocrine Function between Depressed Patients and Normal Patients and Differences in the Physiological Mechanism
More informationPrevalence of anxiety and depressive symptoms in men with erectile dysfunction
Prevalence of anxiety and depressive symptoms in men with erectile dysfunction K Pankhurst, MB ChB G Joubert, BA, MSc P J Pretorius, MB ChB, MMed (Psych) Departments of Psychiatry and Biostatistics, University
More informationCardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003
Authorized By: Medical Management Guideline Committee Approval Date: 12/13/01 Revision Date: 12/11/03 Beta-Blockers Nitrates Calcium Channel Blockers MEDICATIONS Indicated in post-mi, unstable angina,
More informationDepression and Cardiovascular Disease
Available online at www.sciencedirect.com www.onlinepcd.com Depression and Cardiovascular Disease Larkin Elderon a, Mary A. Whooley b, a UCSF School of Medicine, San Francisco, CA b Departments of Medicine,
More informationCardiac Rehabilitation Should be Paid in Korea?
Cardiac Rehabilitation Should be Paid in Korea? Cardiac prevention & Rehabilitation Center, Heart Institute, Asan Medical Center, Seoul, Korea Jong-Young Lee, MD. NO CONFLICT OF INTEREST TO DECLARE Before
More informationDiabetes Care Publish Ahead of Print, published online February 25, 2010
Diabetes Care Publish Ahead of Print, published online February 25, 2010 Undertreatment Of Mental Health Problems In Diabetes Undertreatment Of Mental Health Problems In Adults With Diagnosed Diabetes
More informationJune 2015 MRC2.CORP.D.00030
This program is paid for by Otsuka America Pharmaceutical, Inc. and Lundbeck, LLC. The speaker is a paid contractor of Otsuka America Pharmaceutical, Inc. June 2015 MRC2.CORP.D.00030 advice or professional
More informationDifferential Associations Between Specific Depressive Symptoms and Cardiovascular Prognosis in Patients With Stable Coronary Heart Disease
Journal of the American College of Cardiology Vol. 56, No. 11, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2010.03.080
More informationThe Impact of Depression on Diabetes. Diabetes in Canada. Why is Diabetes a Concern? Lauren C. Brown, BScPharm, MSc, ACPR
The Impact of Depression on Diabetes Lauren C. Brown, BScPharm, MSc, ACPR The Impact of Depression on Mortality and Morbidity Including Other Diseases October 15, 2008 Diabetes in Canada Approximately
More informationARE YOU AT RISK OF A HEART ATTACK OR STROKE? Understand How Controlling Your Cholesterol Reduces Your Risk
ARE YOU AT RISK OF A HEART ATTACK OR STROKE? Understand How Controlling Your Cholesterol Reduces Your Risk CONSIDER YOUR HEART HEALTH: REDUCE YOUR CHOLESTEROL Uncontrolled or continuous high cholesterol
More informationThe Interaction of Depression and Smoking following ACS Andrew M. Busch, PhD
The Interaction of Depression and Smoking following ACS Andrew M. Busch, PhD Senior Psychologist, Dept. of Medicine, HCMC Associate Professor, Dept. of Medicine, University of MN Disclosures No conflicts
More informationThe Relationship between Brachial-Ankle Pulse Wave Velocity and Depressive Symptoms among Patients with Coronary Artery Disease
Brief Report Acta Cardiol Sin 2017;33:303 309 doi: 10.6515/ACS20161021B The Relationship between Brachial-Ankle Pulse Wave Velocity and Depressive Symptoms among Patients with Coronary Artery Disease I-Mei
More informationUniversity of Groningen. Heart in mind mind in heart Tulner, Doriene Marjanka
University of Groningen Heart in mind mind in heart Tulner, Doriene Marjanka IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check
More informationImproving Patient Education and Access to Anxiety Treatment
University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 2014 Improving Patient Education and Access to Anxiety Treatment Heather Gardiner University
More informationDiabetes. & Mental Health. David J. Robinson MD, FRCPC. This slide is for review purposes only and not for presentations.
Diabetes This slide is for review purposes only and not for presentations & Mental Health David J. Robinson MD, FRCPC CMHA - London, ON In the past 2 years, I have received speaking honoraria from, and
More informationAcute coronary syndrome. Dr LM Murray Chemical Pathology Block SA
Acute coronary syndrome Dr LM Murray Chemical Pathology Block SA13-2014 Acute myocardial infarction (MI) MI is still the leading cause of death in many countries It is characterized by severe chest pain,
More informationEDUCATIONAL COMMENTARY CARDIAC FUNCTION: BIOCHEMICAL MARKERS UPDATE
EDUCATIONAL COMMENTARY CARDIAC FUNCTION: BIOCHEMICAL MARKERS UPDATE Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE
More information